THALASSEMIA N ME
Subtitle
GOOD NEWS FOR THALASSEMIA
FDA approves Reblozyl for treatment of anaemia in beta thalassemia in adults needing regular red blood cell (RBC) transfusions. It's designed to regulate late-stage maturation of red blood cells for reducing the RBC transfusion burden for patients.
December 18, 2018
Gates Foundation gives $1.5M to Children's for sickle cell research
July 27, 2018
Bluebird's first gene therapy gets European fast track
Connection to page is not secure. Link at http://www.pmlive.com/pharma_news/bluebirds_first_gene_therapy_gets_european_fast_track_1246019
